Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash-to-Debt 0.06
NAS:CNMD's Cash-to-Debt is ranked lower than
94% of the 269 Companies
in the Global Medical Devices industry.

( Industry Median: 1.84 vs. NAS:CNMD: 0.06 )
Ranked among companies with meaningful Cash-to-Debt only.
NAS:CNMD' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 0.04 Max: 0.28
Current: 0.06
0
0.28
Equity-to-Asset 0.44
NAS:CNMD's Equity-to-Asset is ranked lower than
72% of the 254 Companies
in the Global Medical Devices industry.

( Industry Median: 0.62 vs. NAS:CNMD: 0.44 )
Ranked among companies with meaningful Equity-to-Asset only.
NAS:CNMD' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.29  Med: 0.52 Max: 0.61
Current: 0.44
0.29
0.61
Interest Coverage 2.45
NAS:CNMD's Interest Coverage is ranked lower than
92% of the 228 Companies
in the Global Medical Devices industry.

( Industry Median: 83.04 vs. NAS:CNMD: 2.45 )
Ranked among companies with meaningful Interest Coverage only.
NAS:CNMD' s Interest Coverage Range Over the Past 10 Years
Min: 1.24  Med: 7.65 Max: 11.38
Current: 2.45
1.24
11.38
Piotroski F-Score: 5
Altman Z-Score: 1.81
Beneish M-Score: -2.48
WACC vs ROIC
4.95%
2.78%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating Margin % 4.93
NAS:CNMD's Operating Margin % is ranked higher than
55% of the 257 Companies
in the Global Medical Devices industry.

( Industry Median: 3.60 vs. NAS:CNMD: 4.93 )
Ranked among companies with meaningful Operating Margin % only.
NAS:CNMD' s Operating Margin % Range Over the Past 10 Years
Min: 1.14  Med: 7.27 Max: 11.67
Current: 4.93
1.14
11.67
Net Margin % 1.92
NAS:CNMD's Net Margin % is ranked lower than
53% of the 257 Companies
in the Global Medical Devices industry.

( Industry Median: 2.51 vs. NAS:CNMD: 1.92 )
Ranked among companies with meaningful Net Margin % only.
NAS:CNMD' s Net Margin % Range Over the Past 10 Years
Min: 0.1  Med: 4.3 Max: 5.97
Current: 1.92
0.1
5.97
ROE % 2.52
NAS:CNMD's ROE % is ranked lower than
51% of the 249 Companies
in the Global Medical Devices industry.

( Industry Median: 3.48 vs. NAS:CNMD: 2.52 )
Ranked among companies with meaningful ROE % only.
NAS:CNMD' s ROE % Range Over the Past 10 Years
Min: 0.13  Med: 5.33 Max: 8.77
Current: 2.52
0.13
8.77
ROA % 1.14
NAS:CNMD's ROA % is ranked higher than
51% of the 270 Companies
in the Global Medical Devices industry.

( Industry Median: 0.81 vs. NAS:CNMD: 1.14 )
Ranked among companies with meaningful ROA % only.
NAS:CNMD' s ROA % Range Over the Past 10 Years
Min: 0.08  Med: 3.03 Max: 4.72
Current: 1.14
0.08
4.72
ROC (Joel Greenblatt) % 9.78
NAS:CNMD's ROC (Joel Greenblatt) % is ranked higher than
54% of the 267 Companies
in the Global Medical Devices industry.

( Industry Median: 7.00 vs. NAS:CNMD: 9.78 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
NAS:CNMD' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 1.09  Med: 15.34 Max: 26.66
Current: 9.78
1.09
26.66
3-Year Revenue Growth Rate 0.20
NAS:CNMD's 3-Year Revenue Growth Rate is ranked lower than
67% of the 228 Companies
in the Global Medical Devices industry.

( Industry Median: 4.60 vs. NAS:CNMD: 0.20 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
NAS:CNMD' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -1.2  Med: 1.8 Max: 40.3
Current: 0.2
-1.2
40.3
3-Year EBITDA Growth Rate -4.60
NAS:CNMD's 3-Year EBITDA Growth Rate is ranked lower than
65% of the 198 Companies
in the Global Medical Devices industry.

( Industry Median: 4.50 vs. NAS:CNMD: -4.60 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
NAS:CNMD' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -35.6  Med: -4 Max: 40.7
Current: -4.6
-35.6
40.7
3-Year EPS without NRI Growth Rate -25.90
NAS:CNMD's 3-Year EPS without NRI Growth Rate is ranked lower than
83% of the 194 Companies
in the Global Medical Devices industry.

( Industry Median: 3.20 vs. NAS:CNMD: -25.90 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
NAS:CNMD' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -72  Med: 4.75 Max: 238.2
Current: -25.9
-72
238.2
GuruFocus has detected 3 Warning Signs with Conmed Corp $NAS:CNMD.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» NAS:CNMD's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

CNMD Guru Trades in Q1 2016

Jim Simons 103,781 sh (+144.30%)
Paul Tudor Jones Sold Out
Ken Fisher 386,330 sh (-0.10%)
Mario Gabelli 88,800 sh (-0.78%)
» More
Q2 2016

CNMD Guru Trades in Q2 2016

Steven Cohen 284,800 sh (New)
Ken Fisher 441,386 sh (+14.25%)
Mario Gabelli 88,800 sh (unchged)
Jim Simons 49,081 sh (-52.71%)
» More
Q3 2016

CNMD Guru Trades in Q3 2016

Ken Fisher 633,349 sh (+43.49%)
Mario Gabelli 88,800 sh (unchged)
Steven Cohen Sold Out
Jim Simons Sold Out
» More
Q4 2016

CNMD Guru Trades in Q4 2016

Joel Greenblatt 11,606 sh (New)
Ken Fisher 632,386 sh (-0.15%)
Mario Gabelli 88,600 sh (-0.23%)
» More
» Details

Insider Trades

Latest Guru Trades with CNMD

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 334510    SIC: 3845
Compare:NAS:SPNC, NAS:BABY, NYSE:ITGR, OTCPK:IOBCF, NAS:INGN, NAS:CSII, NAS:MDXG, NAS:CYNO, NAS:OFIX, NYSE:CRY, NAS:GNMK, OTCPK:NHNKY, OTCPK:MZRTF, NAS:ARAY, NYSE:IVC, NAS:AXGN, NAS:EXAC, NAS:ELOS, NAS:CUTR, OTCPK:IPDQF » details
Traded in other countries:EC8.Germany,
Conmed Corp is a medical technology company with an emphasis on surgical devices and equipment for minimally invasive procedures and monitoring. The Company's products serve the clinical areas, surgeons and physicians.

Conmed Corp was incorporated under the laws of the State of New York in 1970. It is a medical technology company with an emphasis on surgical devices and equipment for minimally invasive procedures and monitoring. The Company's products serve the clinical areas, surgeons and physicians in a variety of specialties including orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology. Effective January 1, 2013, the Company is accounting and reporting business as a single segment entity engaged in the development, manufacturing and sale on a basis of surgical devices and related equipment. The business is derived from sales in orthopedic surgery product lines, including sports medicine, powered surgical instruments and sports biologics and tissue. These lines are marketed under a number of reputable brands, including Hall, CONMED Linvatec, Concept and Shutt. The surgical visualization product line offers endoscopic imaging and capture devices for the complete spectrum of surgical needs including 2DHD and 3DHD vision technologies. The general surgery product line offers in the areas ofenergy, endomechanical instrumentation, gastrointestinal, pulmonary and patient monitoring. The products are distributed domestically directly to more than 6,000 hospitals and other healthcare institutions as well as through medical specialty distributors and surgeons. The Company competes in orthopedic, surgical visualization and general surgery medical device markets across the world. The development, manufacture, sale and distribution of its products are subject to regulation by numerous agencies and legislative bodies, including the U.S. Food and Drug Administration (FDA) and comparable foreign counterparts.

Ratios

vs
industry
vs
history
PE Ratio 82.04
CNMD's PE Ratio is ranked lower than
82% of the 157 Companies
in the Global Medical Devices industry.

( Industry Median: 27.24 vs. CNMD: 82.04 )
Ranked among companies with meaningful PE Ratio only.
CNMD' s PE Ratio Range Over the Past 10 Years
Min: 9.85  Med: 34.56 Max: 3185
Current: 82.04
9.85
3185
Forward PE Ratio 22.88
CNMD's Forward PE Ratio is ranked higher than
55% of the 55 Companies
in the Global Medical Devices industry.

( Industry Median: 24.10 vs. CNMD: 22.88 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 82.04
CNMD's PE Ratio without NRI is ranked lower than
83% of the 157 Companies
in the Global Medical Devices industry.

( Industry Median: 28.18 vs. CNMD: 82.04 )
Ranked among companies with meaningful PE Ratio without NRI only.
CNMD' s PE Ratio without NRI Range Over the Past 10 Years
Min: 9.85  Med: 34.56 Max: 3185
Current: 82.04
9.85
3185
Price-to-Owner-Earnings 73.17
CNMD's Price-to-Owner-Earnings is ranked lower than
80% of the 110 Companies
in the Global Medical Devices industry.

( Industry Median: 32.45 vs. CNMD: 73.17 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
CNMD' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 8.55  Med: 24.46 Max: 3333.33
Current: 73.17
8.55
3333.33
PB Ratio 2.04
CNMD's PB Ratio is ranked higher than
66% of the 250 Companies
in the Global Medical Devices industry.

( Industry Median: 3.09 vs. CNMD: 2.04 )
Ranked among companies with meaningful PB Ratio only.
CNMD' s PB Ratio Range Over the Past 10 Years
Min: 0.61  Med: 1.44 Max: 2.88
Current: 2.04
0.61
2.88
PS Ratio 1.56
CNMD's PS Ratio is ranked higher than
69% of the 252 Companies
in the Global Medical Devices industry.

( Industry Median: 3.24 vs. CNMD: 1.56 )
Ranked among companies with meaningful PS Ratio only.
CNMD' s PS Ratio Range Over the Past 10 Years
Min: 0.48  Med: 1.12 Max: 2.29
Current: 1.56
0.48
2.29
Price-to-Free-Cash-Flow 51.21
CNMD's Price-to-Free-Cash-Flow is ranked lower than
75% of the 102 Companies
in the Global Medical Devices industry.

( Industry Median: 29.41 vs. CNMD: 51.21 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
CNMD' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 7.45  Med: 19.9 Max: 10230
Current: 51.21
7.45
10230
Price-to-Operating-Cash-Flow 31.32
CNMD's Price-to-Operating-Cash-Flow is ranked lower than
70% of the 129 Companies
in the Global Medical Devices industry.

( Industry Median: 20.17 vs. CNMD: 31.32 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
CNMD' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 6.22  Med: 13.39 Max: 132.61
Current: 31.32
6.22
132.61
EV-to-EBIT 47.44
CNMD's EV-to-EBIT is ranked lower than
82% of the 137 Companies
in the Global Medical Devices industry.

( Industry Median: 21.56 vs. CNMD: 47.44 )
Ranked among companies with meaningful EV-to-EBIT only.
CNMD' s EV-to-EBIT Range Over the Past 10 Years
Min: -200.6  Med: 23.8 Max: 226.5
Current: 47.44
-200.6
226.5
EV-to-EBITDA 18.30
CNMD's EV-to-EBITDA is ranked lower than
55% of the 142 Companies
in the Global Medical Devices industry.

( Industry Median: 16.07 vs. CNMD: 18.30 )
Ranked among companies with meaningful EV-to-EBITDA only.
CNMD' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.5  Med: 12.9 Max: 43.1
Current: 18.3
5.5
43.1
PEG Ratio 8.12
CNMD's PEG Ratio is ranked lower than
81% of the 78 Companies
in the Global Medical Devices industry.

( Industry Median: 2.42 vs. CNMD: 8.12 )
Ranked among companies with meaningful PEG Ratio only.
CNMD' s PEG Ratio Range Over the Past 10 Years
Min: 1.44  Med: 6.18 Max: 1360.81
Current: 8.12
1.44
1360.81
Shiller PE Ratio 40.74
CNMD's Shiller PE Ratio is ranked higher than
62% of the 50 Companies
in the Global Medical Devices industry.

( Industry Median: 49.99 vs. CNMD: 40.74 )
Ranked among companies with meaningful Shiller PE Ratio only.
CNMD' s Shiller PE Ratio Range Over the Past 10 Years
Min: 10.35  Med: 29.3 Max: 65.96
Current: 40.74
10.35
65.96
Current Ratio 2.90
CNMD's Current Ratio is ranked higher than
64% of the 264 Companies
in the Global Medical Devices industry.

( Industry Median: 2.24 vs. CNMD: 2.90 )
Ranked among companies with meaningful Current Ratio only.
CNMD' s Current Ratio Range Over the Past 10 Years
Min: 1.37  Med: 3.33 Max: 4.12
Current: 2.9
1.37
4.12
Quick Ratio 1.71
CNMD's Quick Ratio is ranked higher than
53% of the 264 Companies
in the Global Medical Devices industry.

( Industry Median: 1.64 vs. CNMD: 1.71 )
Ranked among companies with meaningful Quick Ratio only.
CNMD' s Quick Ratio Range Over the Past 10 Years
Min: 0.48  Med: 1.5 Max: 2.09
Current: 1.71
0.48
2.09
Days Inventory 175.99
CNMD's Days Inventory is ranked lower than
70% of the 246 Companies
in the Global Medical Devices industry.

( Industry Median: 125.61 vs. CNMD: 175.99 )
Ranked among companies with meaningful Days Inventory only.
CNMD' s Days Inventory Range Over the Past 10 Years
Min: 155.56  Med: 165.2 Max: 177.86
Current: 175.99
155.56
177.86
Days Sales Outstanding 70.87
CNMD's Days Sales Outstanding is ranked lower than
52% of the 231 Companies
in the Global Medical Devices industry.

( Industry Median: 66.89 vs. CNMD: 70.87 )
Ranked among companies with meaningful Days Sales Outstanding only.
CNMD' s Days Sales Outstanding Range Over the Past 10 Years
Min: 42.39  Med: 66.74 Max: 74.33
Current: 70.87
42.39
74.33
Days Payable 37.72
CNMD's Days Payable is ranked lower than
70% of the 221 Companies
in the Global Medical Devices industry.

( Industry Median: 58.05 vs. CNMD: 37.72 )
Ranked among companies with meaningful Days Payable only.
CNMD' s Days Payable Range Over the Past 10 Years
Min: 22.06  Med: 26.77 Max: 41.23
Current: 37.72
22.06
41.23

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 1.88
CNMD's Dividend Yield % is ranked higher than
58% of the 189 Companies
in the Global Medical Devices industry.

( Industry Median: 1.74 vs. CNMD: 1.88 )
Ranked among companies with meaningful Dividend Yield % only.
CNMD' s Dividend Yield % Range Over the Past 10 Years
Min: 0.5  Med: 1.77 Max: 2.22
Current: 1.88
0.5
2.22
Dividend Payout Ratio 1.43
CNMD's Dividend Payout Ratio is ranked lower than
89% of the 115 Companies
in the Global Medical Devices industry.

( Industry Median: 0.42 vs. CNMD: 1.43 )
Ranked among companies with meaningful Dividend Payout Ratio only.
CNMD' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.43  Med: 0.69 Max: 1.54
Current: 1.43
0.43
1.54
3-Year Dividend Growth Rate 7.20
CNMD's 3-Year Dividend Growth Rate is ranked lower than
56% of the 78 Companies
in the Global Medical Devices industry.

( Industry Median: 8.40 vs. CNMD: 7.20 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
CNMD' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 0 Max: 10.1
Current: 7.2
0
10.1
Forward Dividend Yield % 1.88
CNMD's Forward Dividend Yield % is ranked higher than
58% of the 181 Companies
in the Global Medical Devices industry.

( Industry Median: 1.81 vs. CNMD: 1.88 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 1.88
CNMD's 5-Year Yield-on-Cost % is ranked lower than
51% of the 225 Companies
in the Global Medical Devices industry.

( Industry Median: 2.00 vs. CNMD: 1.88 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
CNMD' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.5  Med: 1.77 Max: 2.22
Current: 1.88
0.5
2.22
3-Year Average Share Buyback Ratio -0.30
CNMD's 3-Year Average Share Buyback Ratio is ranked higher than
77% of the 203 Companies
in the Global Medical Devices industry.

( Industry Median: -3.40 vs. CNMD: -0.30 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CNMD' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -8.3  Med: 0.4 Max: 1.3
Current: -0.3
-8.3
1.3

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 1.22
CNMD's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
82% of the 126 Companies
in the Global Medical Devices industry.

( Industry Median: 2.19 vs. CNMD: 1.22 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
CNMD' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.77  Med: 0.97 Max: 1.33
Current: 1.22
0.77
1.33
Price-to-Intrinsic-Value-DCF (Earnings Based) 7.67
CNMD's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked lower than
100% of the 22 Companies
in the Global Medical Devices industry.

( Industry Median: 2.39 vs. CNMD: 7.67 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 1.39
CNMD's Price-to-Median-PS-Value is ranked lower than
71% of the 211 Companies
in the Global Medical Devices industry.

( Industry Median: 1.06 vs. CNMD: 1.39 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
CNMD' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.6  Med: 1.01 Max: 2.58
Current: 1.39
0.6
2.58
Price-to-Peter-Lynch-Fair-Value 7.63
CNMD's Price-to-Peter-Lynch-Fair-Value is ranked lower than
93% of the 57 Companies
in the Global Medical Devices industry.

( Industry Median: 1.62 vs. CNMD: 7.63 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
CNMD' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.55  Med: 2.87 Max: 135.11
Current: 7.63
0.55
135.11
Earnings Yield (Greenblatt) % 2.10
CNMD's Earnings Yield (Greenblatt) % is ranked higher than
54% of the 242 Companies
in the Global Medical Devices industry.

( Industry Median: 1.70 vs. CNMD: 2.10 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
CNMD' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 0.4  Med: 4.2 Max: 12.7
Current: 2.1
0.4
12.7
Forward Rate of Return (Yacktman) % 14.93
CNMD's Forward Rate of Return (Yacktman) % is ranked higher than
66% of the 125 Companies
in the Global Medical Devices industry.

( Industry Median: 8.96 vs. CNMD: 14.93 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
CNMD' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -13.3  Med: 6.3 Max: 18.8
Current: 14.93
-13.3
18.8

More Statistics

Revenue (TTM) (Mil) $763.5
EPS (TTM) $ 0.52
Beta0.43
Short Percentage of Float6.25%
52-Week Range $37.11 - 50.16
Shares Outstanding (Mil)27.82

Analyst Estimate

Dec17 Dec18
Revenue (Mil $) 772 803
EPS ($) 1.87 2.11
EPS without NRI ($) 1.87 2.11
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)
» More Articles for NAS:CNMD

Headlines

Articles On GuruFocus.com
Activist Hedge Fund Manager Jerome Lande Buys Stake in Technology Company Sep 25 2015 
Paulson, Mindich and Soros Bought Covidien; Should You? Sep 11 2014 
Weekly CEO Buys Highlight: APD, OCUL, CNMD, OPK, AEGR Aug 04 2014 
Weekly CEO Sells Highlight: Profire energy Inc, Graphic Packaging Holding Co, Seagate Technology PLC Aug 04 2014 
My 5 Favorite High Beta Health Care Dividend Stocks Aug 02 2013 
CONMED Corp. (CNMD) Vice President/Finance/CFO Robert D Jr Shallish sells 6,151 Shares Feb 07 2011 
CONMED Corp. Reports Operating Results (10-Q) Nov 02 2010 
CONMED Corp. Reports Operating Results (10-Q) Aug 03 2010 
CONMED Corp. Reports Operating Results (10-Q) May 05 2010 
CONMED Corp. (CNMD) President & CEO Joseph J Corasanti sells 37,501 Shares Dec 15 2009 

More From Other Websites
New Strong Sell Stocks for February 8th Feb 08 2017
CONMED Corp. :CNMD-US: Earnings Analysis: Q4, 2016 By the Numbers : February 7, 2017 Feb 07 2017
ETFs with exposure to CONMED Corp. : February 6, 2017 Feb 06 2017
CONMED CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Feb 02 2017
CONMED Corp. :CNMD-US: Earnings Analysis: 2016 By the Numbers : February 2, 2017 Feb 02 2017
CONMED (CNMD) Q4 Earnings Miss Estimates, Increase Y/Y Feb 02 2017
Edited Transcript of CNMD earnings conference call or presentation 1-Feb-17 9:30pm GMT Feb 01 2017
Conmed misses Street 4Q forecasts Feb 01 2017
Conmed misses Street 4Q forecasts Feb 01 2017
Conmed Corp Earnings Call scheduled for 4:30 pm ET today Feb 01 2017
CONMED Corporation Announces Fourth Quarter and Fiscal Year 2016 Financial Results Feb 01 2017
CONMED Corp. : CNMD-US: Dividend Analysis : December 15th, 2016 (record date) : By the numbers :... Feb 01 2017
CONMED Corp. breached its 50 day moving average in a Bullish Manner : CNMD-US : February 1, 2017 Feb 01 2017
Q4 2016 Conmed Corp Earnings Release - After Market Close Feb 01 2017
CONMED Corporation to Present at the Leerink Partners 6th Annual Global Healthcare Conference Jan 26 2017
CONMED Corp. – Value Analysis (NASDAQ:CNMD) : January 19, 2017 Jan 19 2017
Bovie Medical Announce Sales Channel Partnership with CONMED for PlazXact™ Jan 19 2017
CONMED Corp. breached its 50 day moving average in a Bearish Manner : CNMD-US : January 18, 2017 Jan 18 2017
CONMED Corporation to Announce Fourth Quarter and Fiscal Year 2016 Financial Results on February 1,... Jan 17 2017
CONMED Corporation to Present at the J.P. Morgan Healthcare Conference Dec 22 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)